Literature DB >> 24532558

Clinical features, outcomes, and cerebrospinal fluid findings in adult patients with central nervous system (CNS) infections caused by varicella-zoster virus: comparison with enterovirus CNS infections.

Hyo-Lim Hong1, Eun Mi Lee, Heungsup Sung, Joong Koo Kang, Sang-Ahm Lee, Sang-Ho Choi.   

Abstract

Varicella-zoster virus (VZV) is known to be associated with central nervous system (CNS) infections in adults. However, the clinical characteristics of VZV CNS infections are not well characterized. The aim of this study was to compare the clinical manifestations, outcomes, and cerebrospinal fluid (CSF) findings in patients with VZV CNS infections with those in patients with enterovirus (EV) CNS infections. This retrospective cohort study was performed at a 2,700-bed tertiary care hospital. Using a clinical microbiology computerized database, all adults with CSF PCR results positive for VZV or EV that were treated between January 1999 and February 2013 were identified. Thirty-eight patients with VZV CNS infection and 68 patients with EV CNS infection were included in the study. Compared with the EV group, the median age in the VZV group was higher (VZV, 35 years vs. EV, 31 years; P = 0.02), and showed a bimodal age distribution with peaks in the third and seventh decade. Encephalitis was more commonly encountered in the VZV group (VZV, 23.7% vs. EV, 4.4%; P = 0.01). The median lymphocyte percentage in the CSF (VZV, 81% vs. EV, 36%; P < 0.001) and the CSF protein level (VZV, 100 mg/dl vs. EV, 46 mg/dl; P < 0.001) were higher in the VZV group. Compared with patients with EV CNS infection, patients with VZV CNS infection developed encephalitis more often and exhibited more intense inflammatory reaction. Nevertheless, both VZV and EV CNS infections were associated with excellent long-term prognosis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  central nervous system infection; enterovirus; varicella-zoster virus

Mesh:

Substances:

Year:  2014        PMID: 24532558     DOI: 10.1002/jmv.23902

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Varicella-zoster meningitis with a late-onset of skin eruption.

Authors:  Anawin Sanguankeo; Sikarin Upala; Suthanya Sornprom; Natanong Thamcharoen
Journal:  BMJ Case Rep       Date:  2015-02-17

2.  A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course and outcome.

Authors:  Guido Calleri; Valentina Libanore; Silvia Corcione; Francesco G De Rosa; Pietro Caramello
Journal:  Infection       Date:  2017-02-24       Impact factor: 3.553

Review 3.  Acyclovir-induced neurotoxicity with a positive cerebrospinal fluid varicella zoster PCR result creating a management dilemma: a case report.

Authors:  Kelli M Robertson; Christopher L Harvey; John M Cunningham
Journal:  J Med Case Rep       Date:  2020-09-18

4.  Clinical utility of cerebrospinal fluid vitamin D-binding protein as a novel biomarker for the diagnosis of viral and bacterial CNS infections.

Authors:  Young Jin Kim; Hương Giang Lê; Byoung-Kuk Na; Bo Gyu Kim; Youn-Kwan Jung; Mutbyul Kim; Heeyoung Kang; Min-Chul Cho
Journal:  BMC Infect Dis       Date:  2021-03-05       Impact factor: 3.090

5.  Herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult population with aseptic meningitis or encephalitis: A nine-year retrospective clinical study.

Authors:  Gha-Hyun Lee; Jiyoung Kim; Hyun-Woo Kim; Jae Wook Cho
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

6.  Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics.

Authors:  Josefin Olausson; Sofia Brunet; Diana Vracar; Yarong Tian; Sanna Abrahamsson; Sri Harsha Meghadri; Per Sikora; Maria Lind Karlberg; Hedvig E Jakobsson; Ka-Wei Tang
Journal:  Sci Rep       Date:  2022-03-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.